|
|
Volumn 341, Issue 13, 1999, Pages 988-992
|
|
Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PLACEBO;
ARTIFACT REDUCTION;
CELL TRANSPLANTATION;
CLINICAL RESEARCH;
FETUS SURGERY;
HUMAN;
MEDICAL ETHICS;
METHODOLOGY;
PARKINSON DISEASE;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
SIMULATION;
SUBSTANTIA NIGRA;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL APPROACH/SOURCE;
CONTROL GROUPS;
EMPIRICAL APPROACH;
FEDERAL GOVERNMENT;
FETAL TISSUE DONATION;
NATIONAL INSTITUTES OF HEALTH;
PROFESSIONAL PATIENT RELATIONSHIP;
RESEARCH SUBJECTS;
REVIEW COMMITTEES;
RISKS AND BENEFITS;
THERAPEUTIC RESEARCH;
UNITED STATES;
ADULT;
ADVISORY COMMITTEES;
CONTROL GROUPS;
DISCLOSURE;
DOUBLE-BLIND METHOD;
ETHICAL REVIEW;
ETHICS COMMITTEES, RESEARCH;
ETHICS, MEDICAL;
FEDERAL GOVERNMENT;
FETAL TISSUE TRANSPLANTATION;
HUMANS;
PARKINSON DISEASE;
PLACEBO EFFECT;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
RESEARCH SUBJECTS;
RISK ASSESSMENT;
SUBSTANTIA NIGRA;
THERAPEUTIC HUMAN EXPERIMENTATION;
|
|
EID: 0033598429
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199909233411311 Document Type: Review |
|
Times cited : (223)
|
|
References (52)
|
